Chemoinformaics analysis of Thevetioside F
Molecular Weight | 476.742 | nRot | 5 |
Heavy Atom Molecular Weight | 424.326 | nRig | 21 |
Exact Molecular Weight | 476.387 | nRing | 5 |
Solubility: LogS | -4.252 | nHRing | 0 |
Solubility: LogP | 5.144 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 87.9812 |
nHD | 4 | BPOL | 52.1668 |
QED | 0.41 |
Synth | 4.905 |
Natural Product Likeliness | 3.088 |
NR-PPAR-gamma | 0.18 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.77 |
Pgp-sub | 0.001 |
HIA | 0.014 |
CACO-2 | -4.811 |
MDCK | 0.000012 |
BBB | 0.785 |
PPB | 0.92767 |
VDSS | 1.165 |
FU | 0.0458689 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.454 |
CYP2c19-inh | 0.031 |
CYP2c19-sub | 0.955 |
CYP2c9-inh | 0.124 |
CYP2c9-sub | 0.496 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.859 |
CYP3a4-inh | 0.107 |
CYP3a4-sub | 0.392 |
CL | 14.074 |
T12 | 0.03 |
hERG | 0.036 |
Ames | 0.018 |
ROA | 0.041 |
SkinSen | 0.295 |
Carcinogencity | 0.008 |
EI | 0.017 |
Respiratory | 0.871 |
NR-Aromatase | 0.37 |
Antiviral | Yes |
Prediction | 0.584769 |